# Nataly

> The Nataly Pad is a medical device that quantifies blood los in real time. At Nataly we are developing a postpartum pad to early detect postpartum hemorrhages by quantifying blood in real time. It is non-electronic, easy to use and deployable in every setting. It is designed to replace current pospartum pads. 

Nataly is a maternal-health medtech startup based in Barcelona. The company is in technological development phases, although an early patent has been filed in 2026. Nataly will reach market entry after passing clinical regulatory and proper CE marking, expected to happen in late 2028-2029.

Information on this website is for general and professional information only. It does not replace clinical judgement, medical advice, or applicable medical-device instructions for use.

## Key pages

- [Nataly home](https://www.natalylife.com/): Overview of Nataly and its approach to postpartum blood-loss quantification.
- [The problem: postpartum haemorrhage](https://www.natalylife.com/problem): Information about postpartum haemorrhage, its clinical relevance, and the need for early recognition.
- [Nataly product](https://www.natalylife.com/product): Description of the Nataly solution, intended purpose, and how it supports postpartum blood-loss monitoring.
- [About Nataly](https://www.natalylife.com/aboutus): Nataly's mission, team, and work in maternal-health innovation.
- [Contact Nataly](https://www.natalylife.com/contact): Contact information for partnerships, clinical collaboration, distribution, and general enquiries.